(Q34272766)

1 August 2017

1 reference

title

Designer drugs: how dangerous are they? (English)

1 reference

1 August 2017

1

L. Reneman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14582803

26 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14582803

26 March 2024

publication date

1 January 2003

1 reference

full work available at URL

1 August 2017

2003

0 references

https://link.springer.com/content/pdf/10.1007/978-3-7091-0541-2_4

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Journal of neural transmission. Supplementum

26 March 2024

published in

1 reference

1 August 2017

issue

66

1 reference

1 August 2017

page(s)

61-83

1 reference

Retracted article on dopaminergic neurotoxicity of MDMA

1 August 2017

cites work

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1126/SCIENCE.1074501

Increased use of amphetamine-type stimulants threatens east Asian countries

12 January 2024

1

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue

26 March 2024

2

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Long-term effects of methamphetamine on the synthesis and metabolism of 5-hydroxytryptamine in various regions of the rat brain

26 March 2024

3

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons

26 March 2024

5

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

[125I]RTI-55: a potent ligand for dopamine transporters

26 March 2024

6

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Selective dopamine transporter inhibition by cocaine analogs

26 March 2024

7

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine.

26 March 2024

8

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Cerebral (1)H MRS alterations in recreational 3, 4-methylenedioxymethamphetamine (MDMA, "ecstasy") users

26 March 2024

9

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

alpha-Methyltyrosine blocks methylamphetamine-induced degeneration in the rat somatosensory cortex

26 March 2024

10

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Is MDMA ('Ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research

26 March 2024

12

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study

26 March 2024

14

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

PET study of [11C]beta-CIT binding to monoamine transporters in the monkey and human brain

26 March 2024

15

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Long-term monoamine depletion, differential recovery, and subtle behavioral impairment following methamphetamine-induced neurotoxicity.

26 March 2024

16

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease.

26 March 2024

17

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

26 March 2024

NIDA research monograph

18

76

316

JW Gibb

1987

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

26 March 2024

MDMA study

19

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Comparison of [3H]paroxetine and [3H]cyanoimipramine for quantitative measurement of serotonin transporter sites in human brain

26 March 2024

20

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss

26 March 2024

21

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.

26 March 2024

23

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Effects of severe global ischemia on N-acetylaspartate and other metabolites in the rat brain

26 March 2024

24

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

p-methylthioamphetamine is a potent new non-neurotoxic serotonin-releasing agent

26 March 2024

26

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices

26 March 2024

27

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

The effects of (+/-)-methylenedioxymethamphetamine and (+/-)-methylenedioxyamphetamine in monkeys trained to discriminate (+)-amphetamine from saline.

26 March 2024

29

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Methamphetamine-induced neurotoxicity: structure activity relationships

26 March 2024

30

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?

26 March 2024

31

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Imaging of serotonin and dopamine transporters in the living human brain.

26 March 2024

33

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates

26 March 2024

34

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

6-[18F]fluoro-L-DOPA-PET studies show partial reversibility of long-term effects of chronic amphetamine in monkeys

26 March 2024

36

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Recovery of striatal dopamine function after acute amphetamine- and methamphetamine-induced neurotoxicity in the vervet monkey

26 March 2024

37

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Caveat emptor: editors beware

26 March 2024

38

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings

26 March 2024

39

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428.

26 March 2024

40

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine

26 March 2024

41

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Neurotoxicity of MDMA and related compounds: anatomic studies

26 March 2024

42

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Hippocampal 1H-MRSI in ecstasy users

26 March 2024

44

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity.

26 March 2024

45

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Human research on MDMA (3,4-methylene- dioxymethamphetamine) neurotoxicity: cognitive and behavioural indices of change

26 March 2024

46

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Drug use and life style among college undergraduates: a 30-year longitudinal study

26 March 2024

49

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission.

26 March 2024

50

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons

26 March 2024

51

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings

26 March 2024

52

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Prefrontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: preliminary report

26 March 2024

53

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Effects of ecstasy (MDMA) on the brain in abstinent users: initial observations with diffusion and perfusion MR imaging

26 March 2024

54

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Validity of [123I]beta-CIT SPECT in detecting MDMA-induced serotonergic neurotoxicity

26 March 2024

55

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

American Journal of Neuroradiology

26 March 2024

56

23

231

L Reneman

2002

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]beta-CIT SPECT study--preliminary report

26 March 2024

57

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Neurotoxic amphetamine analogues: effects in monkeys and implications for humans

26 March 2024

58

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study

26 March 2024

59

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals

26 March 2024

60

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration

26 March 2024

61

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals

26 March 2024

63

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Behavioural and biochemical effects of chronic amphetamine treatment in the vervet monkey

26 March 2024

65

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Histological and ultrastructural evidence that D-amphetamine causes degeneration in neostriatum and frontal cortex of rats

26 March 2024

66

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Paroxetine as an in vivo indicator of 3,4-methylenedioxymethamphetamine neurotoxicity: a presynaptic serotonergic positron emission tomography ligand?

26 March 2024

68

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

123/125IRTI-55, an in vivo label for the serotonin transporter

26 March 2024

69

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients.

26 March 2024

71

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine

26 March 2024

74

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue

26 March 2024

75

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys

26 March 2024

76

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.

26 March 2024

77

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users

26 March 2024

78

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-aminopropane (para-methoxymethamphetamine, PMMA)

26 March 2024

80

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans

26 March 2024

81

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Long-term effects of a priming dose and short-term infusion of amphetamine on striatal dopamine neurons in rats.

26 March 2024

82

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Long-term effects of continuous exposure to amphetamine on brain dopamine concentration and synaptosomal uptake in mice

26 March 2024

83

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain

26 March 2024

84

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

A comparison of the neurotoxic potential of methylenedioxyamphetamine (MDA) and its N-methylated and N-ethylated derivatives

26 March 2024

85

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Increasing MDMA use among college students: results of a national survey

26 March 2024

86

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types

26 March 2024

87

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations.

26 March 2024

88

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.

26 March 2024

90

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.

26 March 2024

91

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine

26 March 2024

92

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Effects of repeated methamphetamine administration on methamphetamine self-administration in rhesus monkeys.

26 March 2024

94

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

Serotonin transporters are located on the axons beyond the synaptic junctions: anatomical and functional evidence

26 March 2024

95

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_4

26 March 2024

Identifiers

0 references

1 reference